InsidersTradesSigma
Explore the complete record of transactions filed by Mendelsohn Alan, Directeur Médical. Director active across 1 companies, notably Timber Pharmaceuticals, Inc.. Aggregated, 4 filings have been recorded. Total volume traded: €16k. The latest transaction was filed on 23 November 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations
Alan Mendelsohn is the Chief Medical Officer at Timber Pharmaceuticals, Inc. He is responsible for overseeing the company's medical activities and clinical research. His medical expertise is essential in guiding product development initiatives and ensuring compliance with regulations.